for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Interface, Inc.

TILE.OQ

Latest Trade

13.33USD

Change

0.35(+2.70%)

Volume

836,752

Today's Range

12.87

 - 

13.35

52 Week Range

10.37

 - 

23.50

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
12.98
Open
13.00
Volume
836,752
3M AVG Volume
7.73
Today's High
13.35
Today's Low
12.87
52 Week High
23.50
52 Week Low
10.37
Shares Out (MIL)
58.43
Market Cap (MIL)
759.04
Forward P/E
8.50
Dividend (Yield %)
2.00

Next Event

Q3 2019 Interface Inc Earnings Release

Latest Developments

More

Interface Q2 Adjusted Earnings Per Share $0.51

Interface says As Part Of Midterm Objectives, See Gross Profit Margin Of 42 Pct

Interface Says On April 23, Gregory Bauer, Chief Accounting Officer, Went On Paid Administrative Leave

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Interface, Inc.

Interface Inc. is engaged in design, production and sale of modular carpet, also known as carpet tile. As of January 1, 2017, the Company marketed its modular carpets in over 110 countries under the brand names Interface and FLOR. The Company operates through three segments: Americas, Europe and Asia-Pacific. The Company distributes its products through two primary channels, including direct sales to end users and indirect sales through independent contractors or distributors. The Company sells an antimicrobial chemical compound under the trademark Intersept that the Company incorporates in all of its modular carpet products. It also sells its TacTiles carpet tile installation system, along with a range of traditional adhesives and products for carpet installation and maintenance that are manufactured by a third party. It also provides turnkey project management services for national accounts and other customers through its InterfaceSERVICES business.

Industry

Textiles - Non Apparel

Contact Info

1280 W Peachtree St NW

+1.770.4376800

https://www.interface.com/US/en-US/global

Executive Leadership

Daniel T. Hendrix

Non-Executive Chairman of the Board

Jay D. Gould

President, Chief Executive Officer, Director

Bruce Andrew Hausmann

Chief Financial Officer, Vice President

Kathleen R. Owen

Chief Human Resource Officer, Vice President

David B. Foshee

Vice President, General Counsel, Secretary

Key Stats

2.50 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

1.0K

2017

1.0K

2018

1.2K

2019(E)

1.3K
EPS (USD)

2016

1.030

2017

1.180

2018

1.490

2019(E)

1.527
Price To Earnings (TTM)
17.37
Price To Sales (TTM)
0.58
Price To Book (MRQ)
2.15
Price To Cash Flow (TTM)
7.78
Total Debt To Equity (MRQ)
191.54
LT Debt To Equity (MRQ)
182.39
Return on Investment (TTM)
4.76
Return on Equity (TTM)
3.90

Latest News

BRIEF-Interface Reports Q1 Earnings Per Share Of $0.25

* Q1 EARNINGS PER SHARE VIEW $0.23 -- THOMSON REUTERS I/B/E/S

BRIEF-Interface Expects To Reiterate Fiscal Year 2018 Outlook‍

* INTERFACE INC SAYS EXPECTS TO REITERATE FISCAL YEAR 2018 OUTLOOK - SEC FILING Source text - http://bit.ly/2IJYAW8 Further company coverage:

BRIEF-Interface Reports Q4 Earnings Per Share $0.07

* INTERFACE REPORTS FOURTH QUARTER AND FISCAL YEAR 2017 RESULTS

BRIEF-Interface Inc reports Q3 earnings $0.32/shr

* Q3 earnings per share view $0.30 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Interface enters amended and restated syndicated facility agreement

* Says on August 8, co entered amended and restated syndicated facility agreement - SEC filing

BRIEF-Interface Q2 earnings per share $0.33

* Q2 earnings per share view $0.31 -- Thomson Reuters I/B/E/S

BRIEF-Interface Q1 EPS $0.21 excluding items

* Q1 earnings per share view $0.23, revenue view $223.4 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Interface Q4 earnings per share $0.28 excluding items

* Interface reports fourth quarter and fiscal year 2016 results

BRIEF-Wafergen Bio-Systems expects total revenue for Q4 2016 to be about $3.9 mln

* Wafergen Bio-systems reports revenue growth in fourth quarter of 2016

BRIEF-Opaleye Management reports 5.12 pct passive stake in Wafergen Bio-Systems

* Opaleye Management Inc reports 5.12 percent passive stake in Wafergen Bio-Systems Inc as of November 17 - sec filing Source text : http://bit.ly/2gChrEM Further company coverage:

BRIEF-WaferGen Bio-Systems announces stockholder approval of merger with Takara Bio

* Wafergen Bio-Systems announces stockholder approval of merger with Takara Bio

BRIEF-WaferGen Bio-Systems reports Q3 loss per share $0.19

* WaferGen Bio-Systems reports results for third quarter 2016

BRIEF-Interface - Senior vice president and cfo Lynch to leave the company

* Interface Inc - on november 2, 2016, co and Patrick Lynch, company's senior vice president and cfo, announced Mr. Lynch's departure from company

BRIEF-Interface Q3 earnings per share $0.25

* Q3 earnings per share view $0.32 -- Thomson Reuters I/B/E/S

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up